Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Liesa Regner-Nelke"'
Autor:
Liesa Regner-Nelke, Bendix Labeit, Christopher Nelke, Wolfram Schwindt, Rainer Dziewas, Sonja Suntrup-Krueger
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background Tuberculous meningitis, a rare but severe form of extrapulmonary tuberculosis, frequently affects cranial nerves. While nerves III, VI and VII are commonly involved, involvement of caudal cranial nerves is rarely described. Here,
Externí odkaz:
https://doaj.org/article/9c25b224a80e4c56a4f2a377e960afec
Autor:
Marc Pawlitzki, Laura Acar, Lars Masanneck, Alice Willison, Liesa Regner-Nelke, Christopher Nelke, Helmut L’hoest, Ursula Marschall, Jens Schmidt, Sven G. Meuth, Tobias Ruck
Publikováno v:
Neurological Research and Practice, Vol 4, Iss 1, Pp 1-11 (2022)
Abstract Background The medical care of patients with myositis is a great challenge in clinical practice. This is due to the rarity of these disease, the complexity of diagnosis and management as well as the lack of systematic analyses. Objectives Th
Externí odkaz:
https://doaj.org/article/d35dd452430440b08d7dcc282b5fb5e0
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
Autor:
Liesa Regner-Nelke, Marc Pawlitzki, Alice Willison, Leoni Rolfes, Sinem-Hilal Oezalp, Christopher Nelke, Tristan Kölsche, Melanie Korsen, Matthias Grothe, Sergiu Groppa, Felix Luessi, Sinah Engel, Gereon Nelles, Eckhard Bonmann, Holger Roick, Anke Friedrich, Philipp Knorn, Harald Landefeld, Zoltan Biro, Michael Ernst, Antonios Bayas, Martina Menacher, Katja Akgün, Christoph Kleinschnitz, Tobias Ruck, Tjalf Ziemssen, Refik Pul, Sven G. Meuth
Publikováno v:
Neurological Research and Practice, Vol 4, Iss 1, Pp 1-11 (2022)
Abstract Background Therapeutic options targeting inflammation in multiple sclerosis (MS) have evolved rapidly for relapsing–remitting MS, whereas few therapies are available for progressive forms of MS, in particular secondary progressive MS (SPMS
Externí odkaz:
https://doaj.org/article/ae53dbd9ba474b64ab5dcb39c73e00f6
Autor:
Saskia Räuber, Alice Willison, Melanie Korsen, Tristan Kölsche, Kristin S. Golombeck, Benedikt Plaack, Julia Schüller, Niklas Huntemann, Leoni Rolfes, Christina B. Schroeter, Christopher Nelke, Liesa Regner-Nelke, Moritz Förster, Marius Ringelstein, Michael Harry Barnett, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, Tobias Ruck, Nico Melzer, Sven G. Meuth, David Kremer
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionGiven the varying severity of coronavirus disease 2019 (COVID-19) and the rapid spread of Severe-Acute-Respiratory-Syndrome-Corona-Virus-2 (SARS-CoV-2), vaccine-mediated protection of particularly vulnerable individuals has gained increas
Externí odkaz:
https://doaj.org/article/92d11ef786fd4e43afeb6455a7fb2b71
Autor:
Liesa Regner-Nelke, Christopher Nelke, Christina B. Schroeter, Rainer Dziewas, Tobias Warnecke, Tobias Ruck, Sven G. Meuth
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 18, p 10087 (2021)
Vitamin E is often associated with health benefits, such as antioxidant, anti-inflammatory and cholesterol-lowering effects. These properties make its supplementation a suitable therapeutic approach in neurodegenerative disorders, for example, Alzhei
Externí odkaz:
https://doaj.org/article/a2933019a39a4f72893f9bbcce9ea22a
Publikováno v:
AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 58:322-334
Meningitis describes an inflammation of the meninges of the brain and spinal cord, which, depending on the etiology, can be a serious disease with high lethality. The suspicion of meningitis therefore requires rapid and adept action. In this paper, w
Autor:
Saskia Räuber, Christina B. Schroeter, Christine Strippel, Christopher Nelke, Tillmann Ruland, Andre Dik, Kristin S. Golombeck, Liesa Regner-Nelke, Manuela Paunovic, Daniela Esser, Christian Münch, Felix Rosenow, Martijn van Duijn, Antonia Henes, Tobias Ruck, Ido Amit, Frank Leypoldt, Maarten J. Titulaer, Heinz Wiendl, Sven G. Meuth, Gerd Meyer zu Hörste, Nico Melzer
Publikováno v:
Journal of Autoimmunity, 135:102985. Academic Press
Autoimmune Encephalitis (AE) spans a group of non-infectious inflammatory conditions of the central nervous system due to an imbalanced immune response. Aiming to elucidate the pathophysiological mechanisms of AE, we applied an unsupervised proteomic
Autor:
Saskia Räuber, Melanie Korsen, Niklas Huntemann, Leoni Rolfes, Thomas Müntefering, Vera Dobelmann, Alexander M Hermann, Tristan Kölsche, Karin von Wnuck Lipinski, Christina B Schroeter, Christopher Nelke, Liesa Regner-Nelke, Jens Ingwersen, Marc Pawlitzki, Bianca Teegen, Michael Harry Barnett, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, Bodo Levkau, Nico Melzer, Tobias Ruck, Sven G Meuth, David Kremer
BackgroundVaccination has proven to be effective in preventing SARS-CoV-2 transmission and severe disease courses. However, immunocompromised patients have not been included in clinical trials and real-world clinical data point to an attenuated immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b37caf94df0296cc6e5ee64b6412906
https://hdl.handle.net/2123/28992
https://hdl.handle.net/2123/28992
Autor:
Christopher Nelke, Christina B Schroeter, Frauke Stascheit, Marc Pawlitzki, Liesa Regner-Nelke, Niklas Huntemann, Ercan Arat, Menekse Öztürk, Nico Melzer, Philipp Mergenthaler, Asmae Gassa, Henning Stetefeld, Michael Schroeter, Benjamin Berger, Andreas Totzeck, Tim Hagenacker, Stefanie Schreiber, Stefan Vielhaber, Hans-Peter Hartung, Andreas Meisel, Heinz Wiendl, Sven G Meuth, Tobias Ruck
ObjectiveMyasthenia gravis (MG) is the most common autoimmune disorder affecting the neuromuscular junction. However, evidence shaping treatment decisions, particularly for treatment-refractory cases, is sparse. Both rituximab and eculizumab may be c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d17a4c83ee2670554b5fe136b0ddad6
https://www.ncbi.nlm.nih.gov/pubmed/35246490
https://www.ncbi.nlm.nih.gov/pubmed/35246490
Autor:
Lars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, Alice Willison, Saskia Räuber, Falk Steffen, Stefan Bittner, Frauke Zipp, Philipp Albrecht, Tobias Ruck, Hans-Peter Hartung, Sven G. Meuth, Marc Pawlitzki
Publikováno v:
Multiple Sclerosis and Related Disorders. 63:103927
The current range of disease-modifying treatments (DMTs) for relapsing-remitting multiple sclerosis (RRMS) has placed more importance on the accurate monitoring of disease progression for timely and appropriate treatment decisions. With a rising numb